World's Best Scientists 2026 revealed!
Joseph J. Schildkraut

Joseph J. Schildkraut

D-Index & Metrics

Neuroscience

D-Index
52
Citations
12367
World Ranking
5251
National Ranking
2351

Best Publications

  • THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE

    Unknown

  • Biogenic Amines and Emotion

    Unknown

  • Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite

    Saul M. Schanberg;Joseph J. Schildkraut;George R. Breese;Irwin J. Kopin

  • Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock

    Geraldine Cassens;Mark Roffman;Alvin Kuruc;Paul J. Orsulak

  • Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.

    Joseph J. Schildkraut;Paul J. Orsulak;Alan F. Schatzberg;Jon E. Gudeman

  • Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

    Joseph J. Schildkraut

  • Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

    A I Green;S V Zimmet;R D Strous;J J Schildkraut

  • Catecholamine metabolism in affective disorders—III

    Unknown

  • The effects of psychoactive drugs on norepinephrine-3H metabolism in brain

    S.M. Schanberg;J.J. Schildkraut;I.J. Kopin

  • Some Biochemical Correlates of Panic Attacks with Agoraphobia and Their Response to a New Treatment

    David V. Sheehan;James H. Coleman;David J. Greenblatt;Kenneth J. Jones

  • Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study.

    Joseph Biederman;David B. Herzog;Timothy M. Rivinus;Gordon P. Harper

  • Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline

    Alan F. Schatzberg;Alan F. Schatzberg;Alan H. Rosenbaum;Paul J. Orsulak;Paul J. Orsulak;William A. Rohde;William A. Rohde

  • Norepinephrine Metabolism and Drugs Used in the Affective Disorders: A Possible Mechanism of Action

    Joseph J. Schildkraut;Saul M. Schanberg;George R. Breese;Irwin J. Kopin

  • Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion

    Robert Watson;Ernest Hartmann;Joseph J. Schildkraut

  • Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine.

    Joseph J. Schildkraut;Andrew Winokur;Clarence W. Applegate

  • Neuropsychopharmacology and the Affective Disorders

    Unknown

  • The effects of lithium ion on H3 -norepinephrine metabolism in brain

    Joseph J. Schildkraut;Saul M. Schanberg;Irwin J. Kopin

  • The effects of lithium salts on the turnover and metabolism of norepinephrine in rat brain

    Joseph J. Schildkraut;Mayada A. Logue;George A. Dodge

  • THE EFFECTS OF PENTOBARBITAL ON THE FATE OF INTRACISTERNALLY ADMINISTERED NOREPINEPHRINE-H3

    Saul M. Schanberg;Joseph J. Schildkraut;Irwin J. Kopin

  • Catecholamine metabolism in affective disorders: I.

    Unknown

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: